Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
Type
Guidance (761)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 741 to 750 of 761
Sort by
Date
Title
Apply sorting
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Varenicline for smoking cessation
TA123
25 July 2007
25 July 2007
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)
TA826
21 September 2022
21 September 2022
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy
TA352
26 August 2015
26 August 2015
Vedolizumab for treating moderately to severely active ulcerative colitis
TA342
5 June 2015
5 June 2015
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma
TA269
12 December 2012
1 January 2015
Venetoclax for treating chronic lymphocytic leukaemia
TA796
15 June 2022
15 June 2022
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
TA765
2 February 2022
2 February 2022
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
TA787
27 April 2022
27 April 2022
Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia
TA663
9 December 2020
9 December 2020
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia
TA561
27 February 2019
27 February 2019
Previous page
1
…
73
74
Current page
75
76
77
Page
75
of
77
Next page
Results per page
10
25
50
All
Back to top